# Development of Clinically High Efficient Platforms for Individualised Treatment of Cervix Cancer

> **NCT05102240** · — · RECRUITING · sponsor: **Tata Memorial Hospital** · enrollment: 1800 (estimated)

## Conditions studied

- Cervix Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05102240
- **Lead sponsor:** Tata Memorial Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2022-02-24
- **Primary completion:** 2026-06-30
- **Final completion:** 2026-06-30
- **Target enrollment:** 1800 (ESTIMATED)
- **Last updated:** 2026-02-20

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05102240

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05102240, "Development of Clinically High Efficient Platforms for Individualised Treatment of Cervix Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05102240. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*